NEXGEL, Inc. (NASDAQ:NXGLW) Short Interest Down 69.2% in January

NEXGEL, Inc. (NASDAQ:NXGLW) was the target of a large decline in short interest during the month of January. As of January 30th, there was short interest totaling 1,621 shares, a decline of 69.2% from the January 15th total of 5,271 shares. Based on an average daily volume of 1,910 shares, the short-interest ratio is presently 0.8 days. Based on an average daily volume of 1,910 shares, the short-interest ratio is presently 0.8 days.

NEXGEL Stock Down 23.1%

NASDAQ:NXGLW traded down $0.04 during trading hours on Friday, hitting $0.13. The company had a trading volume of 1,470 shares, compared to its average volume of 3,742. NEXGEL has a 1 year low of $0.10 and a 1 year high of $0.74. The company has a 50-day moving average of $0.19 and a 200 day moving average of $0.26.

About NEXGEL

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.